Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man

This publication has 11 references indexed in Scilit:

• Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex
  Published by Elsevier ,2002
• Therapeutic brain concentration of the NMDA receptor antagonist amantadine
  Neuropharmacology, 1995
• Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantine
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat — a pharmacokinetic microdialysis study
  European Journal of Pharmacology, 1994
• Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan)
  Neuropharmacology, 1993
• Evidence for Lysosomotropism of Memantine in Cultured Human Cells: Cellular Kinetics and Effects of Memantine on Phospholipid Content and Composition, Membrane Fluidity and β‐Adrenergic Transmission
  Basic & Clinical Pharmacology & Toxicology, 1993
• Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
  European Journal of Pharmacology, 1989
• Wirkungen oraler Memantin-Gaben auf die Parkinson-Symptomatik: Ergebnisse einer placebo-kontrollierten Multicenter-Studie
  Deutsche Medizinische Wochenschrift (1946), 1984